Epione-assisted introducer placement for percutaneous pelvic and spine procedures
Official title: Evaluation of the Epione Robotic System for Image-guided Percutaneous MSK Procedures of the Pelvis and Spine in USA. A Prospective Study on Feasibility, Safety and Accuracy
Run by Precision IO Group · NCT07325578 · Data updated 2026-11-12
This will test whether the Epione device can help doctors place introducers during CT- or CBCT-guided percutaneous pelvic or spine procedures in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Precision IO Group Industry-sponsored |
| Locations | 3 sites (San Diego, California and 2 other locations) |
| Status | Recruiting |
| Started | April 28, 2026 |
| Main results expected | January 2027 |
| Study ends | March 2027 |
| Registry record updated | July 20, 2026 |
| Trial ID | NCT07325578 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 22 or older who are approved for CT- or CBCT-guided percutaneous procedures in the pelvis or thoraco-lumbar spine under general anesthesia, can give informed consent, and have routine-cost coverage are ideal candidates.
✕Probably not a fit
Patients needing procedures outside the specified target areas (including the cervical spine), those who cannot undergo general anesthesia or extra CT/CBCT imaging, pregnant or breastfeeding individuals, or those unable to consent are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This investigational device exemption tests the Epione robotic assistance for introducer placement during CT- or CBCT-guided percutaneous musculoskeletal procedures of the pelvis and thoraco-lumbar spine in adults. Participants will undergo their planned procedure under general anesthesia, with the Epione device used to guide introducer placement instead of freehand technique and with additional intra-procedural CT or CBCT imaging. The primary outcome is the rate of feasible procedures achieved with Epione-assisted introducer placement. The study enrolls adults aged 22 and older at three U.S. centers and follows routine coverage for standard-of-care costs.
Why it matters
Potential benefit: If successful, Epione could make introducer placement more consistent and accurate, potentially reducing procedure time and procedural complications.
How similar studies have gone: Previous work with robot-assisted or image-guided systems has shown improved needle or instrument placement accuracy for spine and pelvic procedures, but the Epione device itself is newly investigational in the U.S.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients ≥22 years old, * Patients approved for CT- or CBCT-guided MSK procedure in the pelvis or spine (except the cervical area) under general anesthesia, * Patients who have signed an IRB-approved informed consent form * Patients approved for coverage by their insurance for routine costs involved in this standard of care procedure * Inclusion criteria linked to the freehand procedure have been discussed and validated Exclusion Criteria: * Patients with contraindication to undergo general anesthesia, * Patients unable to maintain appropriate breathing control, * Patients requiring CT- or CBCT-guided percutaneous procedure on target areas other than those indicated * Patients unable to fully understand all relevant aspects of the clinical study necessary for their decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response, * Pregnant or breast-feeding women, * Patients subject to a legal protection measure, * Patients already participating in another conflicting interventional clinical study, * Patients for whom the scan field of view cannot contain the anatomy of interest, the overlaying skin surface, skin markers and the whole patient reference. * Patients having a coagulation abnormalities or bleeding disorder * Patients having an active infection on the day of intervention * Patients having a history of previous surgery resulting in an existing hardware precluding percutaneous approach * Exclusion criteria linked to the freehand procedure have been discussed and validated
Where it's running
-
UC San Diego
San Diego, California, United States Recruiting -
Baptist Hospital Of Miami, Inc
Miami, Florida, United States Recruiting -
Rush University Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Sean Tutton, MD — UC San Diego
- Study coordinator: Erin Meyers
- Email: clinical.department@quantumsurgical.com
- Phone: 305 731-2901
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Financial help to stop medical costs from hurting families after bone tumor surgery
This study tests whether adding a medical payment case management service to standard care can reduce financial hardship for patients with primary bone tumors undergoing surgery, and for their families.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis
This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.
-
Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults
This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.
-
Vessel-X Bone Filling Container System for Vertebral Augmentation
A new minimally invasive vertebral augmentation approach tests the Vessel-X device to see if it safely improves pain and function in people with osteoporotic vertebral compression fractures.
-
Proximal Humerus Cortical Thickness in Post-Stroke Paresis
This study tests whether measurements of the outer bone thickness of the upper arm (the humerus) on the paretic side after a stroke reflect regional bone loss and how well they agree with standard bone density tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.